MY ACCOUNT | NEWSLETTER |

FDB expands e-prescribing tool to vet care


First Databank Inc., a company providing a platform for drug information for professionals in healthcare, has expanded its offerings from human healthcare to veterinary care. The cloud-based tool, FDB Vela, provides electronic prescribing information to professionals. 

"We believe it's time for a robust and frictionless electronic prescribing connection accessible to all prescribers and pharmacies, including those that care for our tens of millions of pets across the United States," said Bob Katter, president of FDB. "Most human prescriptions are currently written and dispensed using FDB's industry-leading drug knowledge and decision support capabilities, and several years ago we developed a new veterinary drug database to support veterinarians in making the best medication decisions for pets. We view the FDB Vela ePrescribing network as a natural extension to these solutions."

The e-prescribing tool can improve everyday operations by saving time and costs, according to the company. Users can utilize the apps to automate prescribing, and link to existing practice information systems, and pharmacies. 

"The addition of ePrescribing to the veterinary industry is long overdue,” said Lathe Bigler, vice president of clinical network services at FDB and general manager of FDB Vela. “One of our goals in developing FDB Vela was to remove barriers to participation that were preventing many stakeholders—including those in the veterinary industry—from realizing the full benefits of ePrescribing. This is why we have opened our network to vital stakeholders, including veterinarians and veterinary practice information systems, for their benefit and that of their pet parents and patients."


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top